VIPoma Crisis: Immediate and life saving reduction of massive stool volumes on starting treatment with octreotide
SQUMJ-Sultan Qaboos University Medical Journal. 2011; 11 (1): 104-107
in English
| IMEMR
| ID: emr-110246
ABSTRACT
We report the case of a 57-year-old male physician who presented with a life threatening secretory and refractory diarrhoea of around 20 L/day. This was complicated by severe hypotension, hypokalaemia, hypercalcaemia, renal failure requiring dialysis, metabolic acidosis, cardiorespiratory arrest and ventilation for 12 days. His diarrhoea responded immediately to the first dose of a therapeutic trial of subcutaneous octreotide 100 mcg 8 hourly which was started on clinical grounds alone before any investigations were carried out. After one day he was extubated and his blood pressure returned to normal. When a functioning neuroendocrine tumour is suspected clinically, the use of octreotide can, as in this case, be life saving
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Pancreatic Neoplasms
/
Octreotide
/
Tomography, X-Ray Computed
/
Follow-Up Studies
/
Vipoma
Type of study:
Case report
Limits:
Humans
/
Male
Language:
English
Journal:
Sultan Qaboos Univ. Med. J.
Year:
2011
Similar
MEDLINE
...
LILACS
LIS